VET
Vermilion Energy Inc.
Oil & Gas Exploration & Production
Market Cap$1.71B
5Y Perf.+150.0%
Build Your Comparison
Side-by-side financial analysisVET
PBA
JPM
Try popular comparisons:
Stock Comparison
VET vs PBA vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
PBA
Pembina Pipeline Corporation
Oil & Gas Midstream
Market Cap$28.10B
5Y Perf.+93.4%
JPM
JPMorgan Chase & Co.
Banks - Diversified
Market Cap$896.00B
5Y Perf.+241.0%
VET vs PBA vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot |  VET |  PBA |  JPM |
|---|---|---|---|
| Industry | Oil & Gas Exploration & Production | Oil & Gas Midstream | Banks - Diversified |
| Market Cap | $1.71B | $28.10B | $896.00B |
| Revenue (TTM) | $1.81B | $7.57B | $280.33B |
| Net Income (TTM) | $-814M | $1.69B | $57.05B |
| Gross Margin | 35.9% | 40.5% | 60.0% |
| Operating Margin | 20.2% | 34.1% | 25.9% |
| Forward P/E | 11.2x | 16.0x | 14.4x |
| Total Debt | $1.30B | $13.31B | $942.38B |
| Cash & Equiv. | $19M | $106M | $343.34B |
VET vs PBA vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
VET
PBA
JPM
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Vermilion Energy In… (VET) | 100 | 250.0 | +150.0% |
| Pembina Pipeline Co… (PBA) | 100 | 193.4 | +93.4% |
| JPMorgan Chase & Co. (JPM) | 100 | 341.0 | +241.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: VET vs PBA vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: PBA leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Vermilion Energy Inc. is the stronger pick specifically for valuation and capital efficiency and capital preservation and lower volatility. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
🥇PBA emerged as the overall leader. Track its performance:
VET
Vermilion Energy Inc.
The Defensive Pick
VET is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta -0.18, Low D/E 58.6%, current ratio 0.84x
- Beta -0.18, yield 4.1%, current ratio 0.84x
- Lower P/E (11.2x vs 14.4x)
Best for: sleep-well-at-night and defensive
PBA
Pembina Pipeline Corporation
The Income Pick
PBA carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 7 yrs, beta -0.06, yield 4.5%
- Rev growth 5.3%, EPS growth -11.3%, 3Y rev CAGR -12.5%
- 5.3% revenue growth vs VET's -15.0%
Best for: income & stability and growth exposure
JPM
JPMorgan Chase & Co.
The Banking Pick
JPM is the clearest fit if your priority is long-term compounding.
- 465.8% 10Y total return vs PBA's 114.2%
Best for: long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth |  PBA | 5.3% revenue growth vs VET's -15.0% |
| Value |  VET | Lower P/E (11.2x vs 14.4x) |
| Quality / Margins | PBA | 22.3% margin vs VET's -44.9% |
| Stability / Safety | VET | Lower D/E ratio (58.6% vs 260.0%) |
| Dividends | PBA | 4.5% yield, 7-year raise streak, vs JPM's 1.9% |
| Momentum (1Y) | VET | +45.6% vs JPM's +21.8% |
| Efficiency (ROA) | PBA | 4.7% ROA vs VET's -13.8%, ROIC 6.9% vs 3.5% |
VET vs PBA vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
FY 2025
FY 2025
VET vs PBA vs JPM — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLVETLAGGINGJPM
JPMJPMorgan Chase & Co.
1leads
PBAPembina Pipeline Corp…
1leads
VETVermilion Energy Inc.
1leads
6 Total Categories
CATEGORYLEADERvs PBAvs JPMMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
Tied
—
Valuation MetricsMultiples, price ratios, and targets
VET6/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
PBA4/9
Total Returns1Y, 3Y, 5Y total returns with dividends
JPM4/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
Tied
—
Income & Cash Flow (Last 12 Months)
Evenly matched — PBA and JPM each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 154.6x VET's $1.8B. PBA is the more profitable business, keeping 22.3% of every revenue dollar as net income compared to VET's -44.9%. On growth, PBA holds the edge at -10.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | VETVermilion Energy … | PBAPembina Pipeline … | JPMJPMorgan Chase & … |
|---|---|---|---|
| RevenueTrailing 12 months | $1.8B | $7.6B | $280.3B |
| EBITDAEarnings before interest/tax | $1.2B | $3.6B | $81.4B |
| Net IncomeAfter-tax profit | -$814M | $1.7B | $57.0B |
| Free Cash FlowCash after capex | $301M | $2.0B | $100.9B |
| Gross MarginGross profit ÷ Revenue | +35.9% | +40.5% | +60.0% |
| Operating MarginEBIT ÷ Revenue | +20.2% | +34.1% | +25.9% |
| Net MarginNet income ÷ Revenue | -44.9% | +22.3% | +20.4% |
| FCF MarginFCF ÷ Revenue | +16.6% | +26.1% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | -16.4% | -10.4% | — |
| EPS Growth (YoY)Latest quarter vs prior year | -10.9% | +1.3% | +16.0% |
Evenly matched — PBA and JPM each lead in 3 of 6 comparable metrics.
Valuation Metrics
VET leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 16.0x trailing earnings, JPM trades at a 37% valuation discount to PBA's 25.4x P/E. On an enterprise value basis, VET's 3.9x EV/EBITDA is more attractive than JPM's 18.4x.
| Metric | VETVermilion Energy … | PBAPembina Pipeline … | JPMJPMorgan Chase & … |
|---|---|---|---|
| Market CapShares × price | $1.7B | $28.1B | $896.0B |
| Enterprise ValueMkt cap + debt − cash | $2.6B | $37.5B | $1.50T |
| Trailing P/EPrice ÷ TTM EPS | -3.68x | 25.41x | 16.00x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.20x | 15.97x | 14.40x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.90x |
| EV / EBITDAEnterprise value multiple | 3.92x | 13.83x | 18.36x |
| Price / SalesMarket cap ÷ Revenue | 1.35x | 5.05x | 3.20x |
| Price / BookPrice ÷ Book value/share | 1.08x | 2.35x | 2.47x |
| Price / FCFMarket cap ÷ FCF | 7.32x | 15.79x | 8.88x |
VET leads this category, winning 6 of 6 comparable metrics.
Profitability & Efficiency
PBA leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-34 for VET. VET carries lower financial leverage with a 0.59x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), PBA scores 5/9 vs VET's 3/9, reflecting solid financial health.
| Metric | VETVermilion Energy … | PBAPembina Pipeline … | JPMJPMorgan Chase & … |
|---|---|---|---|
| ROE (TTM)Return on equity | -33.7% | +10.0% | +15.9% |
| ROA (TTM)Return on assets | -13.8% | +4.7% | +1.3% |
| ROICReturn on invested capital | +3.5% | +6.9% | +4.5% |
| ROCEReturn on capital employed | +3.3% | +8.4% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 5 | 5 |
| Debt / EquityFinancial leverage | 0.59x | 0.79x | 2.60x |
| Net DebtTotal debt minus cash | $1.3B | $13.2B | $599.0B |
| Cash & Equiv.Liquid assets | $19M | $106M | $343.3B |
| Total DebtShort + long-term debt | $1.3B | $13.3B | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | 2.53x | 4.44x | 0.74x |
PBA leads this category, winning 4 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
JPM leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $14,136 for VET. Over the past 12 months, VET leads with a +45.6% total return vs JPM's +21.8%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs VET's 1.3% — a key indicator of consistent wealth creation.
| Metric | VETVermilion Energy … | PBAPembina Pipeline … | JPMJPMorgan Chase & … |
|---|---|---|---|
| YTD ReturnYear-to-date | +31.7% | +26.7% | -0.5% |
| 1-Year ReturnPast 12 months | +45.6% | +32.5% | +21.8% |
| 3-Year ReturnCumulative with dividends | +4.0% | +73.5% | +138.2% |
| 5-Year ReturnCumulative with dividends | +41.4% | +74.7% | +118.2% |
| 10-Year ReturnCumulative with dividends | -39.7% | +114.2% | +465.8% |
| CAGR (3Y)Annualised 3-year return | +1.3% | +20.2% | +33.6% |
JPM leads this category, winning 4 of 6 comparable metrics.
Risk & Volatility
Evenly matched — VET and PBA each lead in 1 of 2 comparable metrics.
Risk & Volatility
VET is the less volatile stock with a -0.18 beta — it tends to amplify market swings less than JPM's 0.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PBA currently trades 96.5% from its 52-week high vs VET's 75.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | VETVermilion Energy … | PBAPembina Pipeline … | JPMJPMorgan Chase & … |
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.18x | -0.06x | 0.94x |
| 52-Week HighHighest price in past year | $14.82 | $50.10 | $337.25 |
| 52-Week LowLowest price in past year | $7.00 | $35.45 | $262.71 |
| % of 52W HighCurrent price vs 52-week peak | +75.2% | +96.5% | +95.1% |
| RSI (14)Momentum oscillator 0–100 | 40.9 | 56.9 | 59.1 |
| Avg Volume (50D)Average daily shares traded | 1.3M | 949K | 7.0M |
Evenly matched — VET and PBA each lead in 1 of 2 comparable metrics.
Analyst Outlook
Evenly matched — PBA and JPM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: VET as "Hold", PBA as "Buy", JPM as "Buy". Consensus price targets imply 5.9% upside for JPM (target: $340) vs -19.8% for PBA (target: $39). For income investors, PBA offers the higher dividend yield at 4.50% vs JPM's 1.86%.
| Metric | VETVermilion Energy … | PBAPembina Pipeline … | JPMJPMorgan Chase & … |
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $10.74 | $38.76 | $339.75 |
| # AnalystsCovering analysts | 10 | 16 | 61 |
| Dividend YieldAnnual dividend ÷ price | +4.1% | +4.5% | +1.9% |
| Dividend StreakConsecutive years of raises | 3 | 7 | 15 |
| Dividend / ShareAnnual DPS | $0.64 | $3.04 | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.5% | 0.0% | +3.9% |
Evenly matched — PBA and JPM each lead in 1 of 2 comparable metrics.
Key Takeaway
VET leads in 1 of 6 categories (Valuation Metrics). PBA leads in 1 (Profitability & Efficiency). 3 tied.
Best OverallVermilion Energy Inc. (VET)Leads 1 of 6 categories
Loading custom metrics...
VET vs PBA vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is VET or PBA or JPM a better buy right now?
For growth investors, Pembina Pipeline Corporation (PBA) is the stronger pick with 5.
3% revenue growth year-over-year, versus -15. 0% for Vermilion Energy Inc. (VET). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 0x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate Pembina Pipeline Corporation (PBA) a "Buy" — based on 16 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — VET or PBA or JPM?
On trailing P/E, JPMorgan Chase & Co.
(JPM) is the cheapest at 16. 0x versus Pembina Pipeline Corporation at 25. 4x. On forward P/E, Vermilion Energy Inc. is actually cheaper at 11. 2x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — VET or PBA or JPM?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +118. 2%, compared to +41. 4% for Vermilion Energy Inc. (VET). Over 10 years, the gap is even starker: JPM returned +465. 8% versus VET's -39. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — VET or PBA or JPM?
By beta (market sensitivity over 5 years), Vermilion Energy Inc.
(VET) is the lower-risk stock at -0. 18β versus JPMorgan Chase & Co. 's 0. 94β — meaning JPM is approximately -617% more volatile than VET relative to the S&P 500. On balance sheet safety, Vermilion Energy Inc. (VET) carries a lower debt/equity ratio of 59% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — VET or PBA or JPM?
By revenue growth (latest reported year), Pembina Pipeline Corporation (PBA) is pulling ahead at 5.
3% versus -15. 0% for Vermilion Energy Inc. (VET). On earnings-per-share growth, the picture is similar: JPMorgan Chase & Co. grew EPS 1. 5% year-over-year, compared to -1313. 3% for Vermilion Energy Inc.. Over a 3-year CAGR, PBA leads at -12. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — VET or PBA or JPM?
Pembina Pipeline Corporation (PBA) is the more profitable company, earning 21.
8% net margin versus -37. 0% for Vermilion Energy Inc. — meaning it keeps 21. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PBA leads at 36. 1% versus 9. 5% for VET. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is VET or PBA or JPM more undervalued right now?
On forward earnings alone, Vermilion Energy Inc.
(VET) trades at 11. 2x forward P/E versus 16. 0x for Pembina Pipeline Corporation — 4. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for JPM: 5. 9% to $339. 75.
08Which pays a better dividend — VET or PBA or JPM?
All stocks in this comparison pay dividends.
Pembina Pipeline Corporation (PBA) offers the highest yield at 4. 5%, versus 1. 9% for JPMorgan Chase & Co. (JPM).
09Is VET or PBA or JPM better for a retirement portfolio?
For long-horizon retirement investors, Vermilion Energy Inc.
(VET) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 18), 4. 1% yield). Both have compounded well over 10 years (VET: -39. 7%, JPM: +465. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between VET and PBA and JPM?
These companies operate in different sectors (VET (Energy) and PBA (Energy) and JPM (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: VET is a small-cap income-oriented stock; PBA is a mid-cap income-oriented stock; JPM is a large-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.